title: Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations.
authors.forename: Antonio
authors.initials: A
authors.lastname: Garrido Serrano
authors.forename: Rafael
authors.initials: R
authors.lastname: León
authors.forename: Manuel
authors.initials: M
authors.lastname: Sayago
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Márquez
mesh_terms: D000368:Aged; D000740:Anemia / Q000209:etiology*; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006501:Hepatic Encephalopathy / Q000139:chemically induced; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D012008:Recurrence; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D054079:Vascular Malformations / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide
references.citation: Eur J Gastroenterol Hepatol. 2006 May;18(5):545-8
references.pmid: 16607153
references.citation: Dig Dis Sci. 2011 Jan;56(1):266-7
references.pmid: 21046246
references.citation: Endoscopy. 2006 Oct;38(10):1036-9
references.pmid: 17058171
references.citation: Gastroenterology. 2011 Nov;141(5):1629-37.e1-4
references.pmid: 21784047
references.citation: World J Gastroenterol. 2006 Nov 21;12(43):6955-60
references.pmid: 17109516
references.citation: Gut. 2006 Sep;55(9):1371-2
references.pmid: 16905712
references.citation: Pharmacotherapy. 2006 Jul;26(7):1018-22
references.pmid: 16803426
references.citation: Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1347-50
references.pmid: 19730385
references.citation: Hepatogastroenterology. 2011 May-Jun;58(107-108):971-9
references.pmid: 21830426